Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.52 |
| ▸ | APBA1 | Q02410 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | S100A4 | P26447 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30503415 | 1.00 | PADI4 (0.55) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| SCHEMBL27740 | 0.92 | IDO1 (0.53) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| SCHEMBL29648165 | 0.92 | IDO1 (0.53) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| Formaldehyde SCHEMBL11154820 | 0.90 | PADI4 (0.54) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| SCHEMBL526630 | 0.88 | IDO1 (0.56) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| SCHEMBL7206757 | 0.85 | IDO1 (0.53) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| SCHEMBL7206760 | 0.85 | IDO1 (0.53) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| Water SCHEMBL28866381 | 0.85 | KDM4E (0.60) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| SCHEMBL599214 | 0.83 | MAPT (0.54) | PADI4HSP90AA1IDO1KDM4EMAPT | |
| SCHEMBL30110472 | 0.83 | MAPT (0.54) | PADI4HSP90AA1IDO1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111315716-B | Process for producing formic acid | 索尔维公司 | 2023-04-14 | — | — | CN | claimed |
| CN-111315716-A | Process for producing formic acid | 索尔维公司 | 2020-06-19 | — | — | CN | claimed |
| CN-105228973-B | Process for the oligomerization of ethylene to a mixture of 1-hexene and 1-octene | 沙索技术有限公司 | 2017-08-29 | — | — | CN | claimed |
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
| US-4086265-A | Preparation of catechol derivatives | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1978-04-25 | — | — | US | claimed |
| US-20250170252-A1 | QUINONE PROTECTED FORMS AND CONJUGATES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-05-29 | — | — | US | disclosed |
| CN-120020108-A | Method for synthesizing hydroquinone | 南京理工大学 | 2025-05-20 | — | — | CN | disclosed |
| EP-4532480-A1 | QUINONE PROTECTED FORMS AND CONJUGATES | Cambridge Enterprise Limited (GB) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023227757-A1 | QUINONE PROTECTED FORMS AND CONJUGATES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2023-11-30 | — | — | WO | disclosed |
| CN-111315716-B | Process for producing formic acid | 索尔维公司 | 2023-04-14 | — | — | CN | disclosed |
| EP-0036710-B1 | PHENANTHRENE BASED POLYIMIDE RESIN | Coal Industry (Patents) Limited (GB) | 1984-01-25 | — | — | EP | disclosed |
| US-4394499-A | GLASS CLOTH LAMINATES; AROMATIC-ALDEHYDE OLIGOMER REACTED WITH AN AROMATIC DIAMINE | COAL INDUSTRY (PATENTS) LIMITED (GB) | 1983-07-19 | — | — | US | disclosed |
| US-4373089-A | Phenanthrene based polyimide resin | COAL INDUSTRY (PATENTS) LIMITED (GB) | 1983-02-08 | — | — | US | disclosed |
| EP-0036710-A1 | Phenanthrene based polyimide resin | Coal Industry (Patents) Limited (GB) | 1981-09-30 | — | — | EP | disclosed |
| US-4086265-A | Preparation of catechol derivatives | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1978-04-25 | — | — | US | disclosed |
| US-3973966-A | Photochromic composition containing a diphenyl dibenzochrom-3-ene | XEROX CORPORATION (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | PADI4 4497/4885HSP90AA1 4349/4885IDO1 425/4885 |
| US-20250170252-A1 | QUINONE PROTECTED FORMS AND CONJUGATES | NQO1, SQOR, GSTP1 | PADI4 3259/4885HSP90AA1 1909/4885IDO1 932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.